Chemotherapy for Leukemia Novel Drugs and Treatment /
This book focuses on the latest progress in chemotherapy for leukemia and related diseases, including still-ongoing but promising studies. The effectiveness of treatment for chronic myeloid leukemia and acute promyelocytic leukemia has been dramatically improved in recent years. This improvement has...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Singapore :
Springer Singapore : Imprint: Springer,
2017.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- 1 An Overview
- Part I Bcr-Abl Tyrosine Kinase Inhibitors (TKIs)
- 2 Imatinib: Basic Results
- 3 Imatinib: Clinical Pharmacology and Therapeutic Results
- 4 Dasatinib, Nilotinib, Bosutinib, Ponatinib, and Other TKIs
- Part II New Antibodies for Leukemia
- 5 Rituximab and Alemtuzumab for Chronic Lymphocytic Leukemia: Basic Results
- 6 Rituximab and Alemtuzumab for Chronic Lymphocytic Leukemia: Clinical Pharmacology and Therapeutic Results
- 7 Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia: Clinical Pharmacology and Therapeutic Results
- 8 Blinatumomab for Acute Lymphoblastic Leukemia: Clinical Pharmacology and Therapeutic Results
- 9 Mogamulizumab in Adult T-cell Leukemia/Lymphoma
- Part III Signaling inhibitors
- 10. FLT3 inhibitors
- Part IV Differentiating Agents
- 11 Retinoic Acid, All-Trans Retinoic Acid (ATRA) and Tamibarotene
- 12 The Molecular Basis of Arsenic Trioxide Treatment for Acute Promyelocytic Leukemia (APL)
- 13 Arsenic Trioxide: Clinical Pharmacology and Therapeutic Results
- Part V New Chemotherapeutic Agents Including Antimetabolite
- 14 Nelarabine
- 15 Forodesine
- 16 Clofarabine: Structure, Mechanism of Action, and Clinical Pharmacology
- 17 Clinical Use of Clofarabine for Adults and Children with Leukemia
- 18 Re-Emerging Antimetabolites with Novel Mechanism of Action with Respect to Epigenetic Regulation: Basic Aspects
- 19 Epigenetic Regulator, Re-Emerging Antimetabolites with Novel Mechanism of Action (Azacitidine and Decitabine): Clinical Pharmacology and Therapeutic Results
- Part VI Therapy Targeting Leukemic Stem Cells
- 20 Therapies Targeting Leukemic Stem Cells.
